JWH-130

JWH-130 is a synthetic cannabinoid from the naphthoylindole family, which acts as a potent agonist at both the CB₁ and CB₂ receptors, with a slight preference for CB₂. It was discovered by and named after Dr. John W. Huffman.

Chemistry

JWH-130 is part of the naphthoylindole family of synthetic cannabinoids. It is structurally related to compounds such as JWH-018 and JWH-073, which are also potent agonists of the CB₁ and CB₂ receptors.

Pharmacology

JWH-130 acts as a potent agonist at both the CB₁ and CB₂ receptors, with a slight preference for CB₂. The CB₁ receptor is primarily located in the brain, and is responsible for the psychoactive effects of cannabinoids. The CB₂ receptor is primarily found in the immune system, and is involved in a variety of physiological processes.

Effects

The effects of JWH-130 are similar to those of other synthetic cannabinoids and include psychoactive effects, analgesic effects, and anti-inflammatory effects. However, the exact effects can vary depending on the individual and the dose.

Legal Status

The legal status of JWH-130 varies by country. In some countries, it is classified as a controlled substance, while in others it is legal.

See Also

• Synthetic cannabinoids
• Cannabinoid receptor
• JWH-018
• JWH-073

References

JWH-130 Resources
Latest articles Most recent articles Ongoing trials	Wikipedia